Home > Marketing > Multi-National Pharmaceutical Leader Inks Enterprise HCP Email Deal with Redi-Data, Inc.

Multi-National Pharmaceutical Leader Inks Enterprise HCP Email Deal with Redi-Data, Inc.

Added: (Wed Dec 06 2017)

Pressbox (Press Release) - Redi-Data, Inc., a leading provider of healthcare professional, consumer and business data and email lists, announced today, that a leading top 12 global pharmaceutical company has reached an agreement to license its comprehensive database of over 1.2 million HCP emails. The company will leverage Redi-Data’s healthcare email database across its portfolio of leading brands and best-in-class products to target and streamline marketing outreach initiatives.



The Enterprise License Agreement provides the pharmaceutical leader with cost-effective access to email data by specialty and a wide range of medical professions, including MDs, DOs, NPs, PAs, Dentists and Nurses. The company will also leverage Redi-Data’s expert campaign coordination and support, including email deployment, sophisticated reporting, database management and handling of opt-outs.



“This is a significant partnership for Redi-Data,” stated Thomas Buckley, President of Redi-Data, Inc. “The quality of both our data and client support were evaluated as part of this process and we remain committed to delivering the best value to our clients while turning the best data into better business.”



About Redi-Data, Inc.


Redi-Data, Inc. is a leading provider of healthcare professional, consumer and business postal and email lists. As an official database licensee of several leading professional associations, including the American Medical Association (AMA), Redi-Data provides physician information from the most trusted names in medical marketing. Clients across varying industries use Redi-Data’s high-quality lists, data services and turn-key marketing solutions to reach their target audience accurately and affordably. Headquartered in Fairfield, NJ, Redi-Data has sales offices in Marlton, NJ and Sunrise, FL.

Submitted by:Michael San Inocencio
Disclaimer: Pressbox disclaims any inaccuracies in the content contained in these releases. If you would like a release removed please send an email to remove@pressbox.co.uk together with the url of the release.